Eligibility for Semaglutide 2.4 mg in US Adults with Obesity and Prediabetes, Based on the STEP-10 Trial Criteria

被引：0
|
作者：
Chetty, Ashwin K.
Khunte, Mihir
Lu, Yuan
Chen, Alissa S.
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Brown Univ, Warren Alpert Med Sch, Providence, RI USA
[3] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT USA
[4] Yale Sch Med, Dept Internal Med, Natl Clinician Scholars Program, New Haven, CT USA
来源：
AMERICAN HEART JOURNAL | 2024年 / 278卷
关键词：
obesity; prediabetes; semaglutide;
D O I：
10.1016/j.ahj.2024.09.026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0057
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Once-weekly semaglutide 2.4 mg improved glucose metabolism and prediabetes in adults with overweight or obesity in the STEP 1 trial
    Perreault, L.
    Davies, M.
    Frias, J. P.
    Laursen, P. N.
    Lingvay, I.
    Machineni, S.
    Varbo, A.
    Wilding, J. P. H.
    Wallenstein, S. O. R.
    Le Roux, C. W.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 234 - 234
  • [2] Once-Weekly Semaglutide 2.4 mg Improved Glucose Metabolism and Prediabetes in Adults with Overweight/Obesity in the STEP 1 Trial
    Perreault, Leigh
    Davies, Melanie J.
    Frias, Juan P.
    Laursen, Peter N.
    Lingvay, Ildiko
    Machineni, Sriram
    Varbo, Anette
    Wilding, John
    Wallenstein, Signe O. R.
    Le Roux, Carel
    DIABETES, 2021, 70
  • [3] Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg (STEP 8)
    Idris, Iskandar
    Rubino, Domenica
    Garvey, W. Timothy
    Goldman, Bryan
    Khalid, Usman
    Rosenstock, Julio
    Sorrig, Rasmus
    OBESITY SURGERY, 2023, 33 : S39 - S39
  • [4] Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg (STEP 8)
    Rubino, D. M.
    Garvey, T. W.
    Goldman, B.
    Khalid, U.
    Rosenstock, J.
    Sorrig, R.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S287 - S288
  • [5] Semaglutide 2.4 mg Improved Glucose Metabolism and Reverted Prediabetes to Normoglycemia in Adults with Overweight/Obesity vs. Liraglutide 3.0 mg (STEP 8)
    Rosenstock, Julio
    Garvey, W. Timothy
    Goldman, Bryan
    Khalid, Usman
    Sorrig, Rasmus
    Rubino, Domenica
    DIABETES, 2022, 71
  • [6] Semaglutide 2.4 mg Improves Health -Related Quality of Life in Adults with Overweight/Obesity and Type 2 Diabetes in the STEP 2 Trial
    Rubino, Domenica
    Faerch, Louise
    Meincke, Henrik H.
    Kushner, Robert F.
    Pedersen, Sue
    Ryan, Donna H.
    Wharton, Sean
    Zeuthen, Niels
    Kolotkin, Ronette
    DIABETES, 2021, 70
  • [7] Effect of semaglutide 2.4 mg on glucose metabolism and body weight in adults with overweight or obesity and type 2 diabetes in the STEP 2 trial
    Pedersen, S. D.
    Davies, M.
    Faerch, L.
    Jeppesen, O. K.
    Pakseresht, A.
    Perreault, L.
    Rosenstock, J.
    Shimomura, I.
    Viljoen, A.
    Wadden, T.
    Lingvay, I.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 13 - 13
  • [8] Effect of Semaglutide 2.4 mg on Glucose Metabolism and Body Weight in Adults with Overweight/Obesity and Type 2 Diabetes in the STEP 2 Trial
    Perreault, Leigh
    Davies, Melanie J.
    Faerch, Louise
    Jeppesen, Ole
    Pakseresht, Arash
    Pedersen, Sue
    Rosenstock, Julio
    Shimomura, Iichiro
    Viljoen, Adie
    Wadden, Thomas A.
    Lingvay, Ildiko
    DIABETES, 2021, 70
  • [9] Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5
    Wharton, Sean
    Batterham, Rachel L.
    Bhatta, Meena
    Buscemi, Silvio
    Christensen, Louise N.
    Frias, Juan P.
    Jodar, Esteban
    Kandler, Kristian
    Rigas, Georgia
    Wadden, Thomas A.
    Garvey, W. Timothy
    OBESITY, 2023, 31 (03) : 703 - 715
  • [10] Two-year Effect of Semaglutide 2.4 mg vs Placebo in Adults with Overweight or Obesity: STEP 5
    Garvey, W. Timothy
    Batterham, Rachel
    Bhatta, Meena
    Buscemi, Silvio
    Christensen, Louise
    Frias, Juan
    Jodar, Esteban
    Kandler, Kristian
    Rigas, Georgia
    Wadden, Thomas
    Wharton, Sean
    OBESITY, 2021, 29 : 43 - 43
12345